Livzon Group Fuzhou Fuxing Pharmaceutical is an API manufacturer based in China. It holds 15 active US drug master files and 14 valid CEPs across a filed portfolio of 17 molecules. Its GMP standing is certified by US FDA and EMA. Its most recent recorded inspection, by US FDA, closed on 5 April 2024 as NAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Fuzhou, China | Not on file |
| Jiangyin, China | Not on file |
| Fujian, China | Not on file |
| China, China | 3006772356 |
| Molecule | Regulators | Docs |
|---|---|---|
| Colistimethate | EDQM, SFDA (Saudi Arabia), US FDA | 4 |
| Tobramycin | EDQM, US FDA | 4 |
| Vancomycin | SFDA (Saudi Arabia), US FDA | 4 |
| Daptomycin | SFDA (Saudi Arabia), US FDA | 3 |
| Teicoplanin | EDQM, SFDA (Saudi Arabia) | 3 |
| Vancomycin Hydrochloride | EDQM | 3 |
| Acarbose | EDQM, US FDA | 2 |
| Milbemycin Oxime For Veterinary Use | EDQM | 2 |
| Polymyxin B | EDQM, US FDA | 2 |
| Colistin | EDQM | 1 |
| Dalbavancin | US FDA | 1 |
| Gentamicin | US FDA | 1 |
| Kanamycin | US FDA | 1 |
| Moxidectin | US FDA | 1 |
| Moxidectin For Veterinary Use | EDQM | 1 |
| Sirolimus | US FDA | 1 |
| Telavancin | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 1 | None |
| US FDA | None | 1 |
| EMA | None | 1 |
Choose your molecules and target markets. Livzon Group Fuzhou Fuxing Pharmaceutical comes back tiered against every other supplier able to file there.
Start for free